ERBB2 and breast cancer: The expression of the estrogen receptor (ER) and the progesterone receptor (PR), as well as the amplified status of human epidermal growth factor receptor 2 (HER2), are parameters involved in the current classification of breast cancer, and they are also used to identify the most useful therapeutic approaches.